Sunday, January 03, 2016 9:40:03 AM
Hema isn't all of RGBP's focus and isn't its only savior. Its the first stepping stone of legitimacy as far as the FDA is concerned. Whether it works is a different story, however we will learn shortly.
The test results if proven successful will give koos and lander bargaining power. When dCell, the 2nd or 2/2 of regens first 2 inds gets approved will give koos and lander bargaining power. These drugs in humans have to show a "very" promising human result and if/when they do, money wont be a issue whether it be for funding or for funding trials.
Hopes for sitting pretty later on is why I'm still here. Honestly, I am looking forward to how the human trials go just scientifically more than a small or slight incline/decline in the pps. Who knows.
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM